SCHEMBL4552410

SCHEMBL4552410

O=S(=O)(O)c1cccc(N=Nc2c(O)ccc3ccccc23)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 1.00
▸ KMT2A Q03164 4/20 1.00
▸ TDP1 Q9NUW8 3/20 1.00
▸ MAPK1 P28482 3/20 1.00
▸ GAA P10253 2/20 1.00
▸ GLO1 Q04760 3/20 0.81
▸ CYP1A2 P05177 3/20 0.68
▸ CYP2C9 P11712 2/20 0.68
▸ HIF1A Q16665 2/20 0.68
▸ TSHR P16473 1/20 0.68
▸ PTPRA P18433 1/20 0.68
▸ PTPRB P23467 1/20 0.68
▸ CYP2C19 P33261 1/20 0.68
▸ RAPGEF4 Q8WZA2 1/20 0.68
▸ HSD17B10 Q99714 1/20 0.68
▸ THRB P10828 3/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ MPL P40238 3/20 0.62
▸ CTRC Q99895 1/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617673 0.90 KMT2A (0.81) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL4617674 0.90 KMT2A (0.81) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL19000765 0.88 MAPT (0.79) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL15424235 0.85 MAPT (0.74) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL8947456 0.85 MAPT (0.74) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL11336943 0.85 MAPT (0.80) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL4412992 0.85 MAPT (0.80) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL29376978 0.85 MAPT (0.80) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL92162 0.85 MAPT (0.80) MAPTKMT2ATDP1MAPK1GAA
SCHEMBL109165 0.85 MAPT (0.80) MAPTKMT2ATDP1MAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9428392-B2 Methods of enriching different species of carbon nanotubes NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-08-30 — — US disclosed
US-20140308194-A1 METHODS OF ENRICHING DIFFERENT SPECIES OF CARBON NANOTUBES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-10-16 — — US disclosed
WO-2013062488-A1 METHODS OF ENRICHING DIFFERENT SPECIES OF CARBON NANOTUBES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-05-02 — — WO disclosed
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE ENGELS PETER 2009-12-31 — — US disclosed
US-4812512-A SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES ROUSSEL UCLAF (FR) 1989-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324656-A1 COSMETIC PREPARATIONS WITH AN ADDITIVE FROM THE BAOBAB TREE CUTA, BROX, MANBA MAPT 497/4885KMT2A 2289/4885TDP1 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback